Dexamethasone, Carfilzomib, & Nivolumab With Pelareorep for Relapsed/Refractory Multiple Myeloma
- Status
- COMPLETED
- Phase
- PHASE1
Clinical Trials Related to Bristol-Myers Squibb
Related studies linked through entity extraction aliases.
The Immunogenicity and Safety of Zostavax® and Shingrix® in Rheumatoid Arthritis Patients Using Abatacept
- Status
- COMPLETED
- Phase
- PHASE2
Checkpoint Inhibitor Induced Colitis and Arthritis -Immunomodulation With IL-6 Blockade and Exploration of Disease Mechanisms
- Status
- COMPLETED
- Phase
- NA
pTVG-HP and Nivolumab in Patients With Non-Metastatic PSA-Recurrent Prostate Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
An Investigational Study of Experimental Medication BMS-986165 in Participants With Moderate to Severe Crohn's Disease
- Status
- TERMINATED
- Phase
- PHASE2
The Study of How Long Participants Stay in the Hospital After Receiving Apixaban for a Blood Clot in the Lung
- Status
- COMPLETED
- Phase
- N/A
Efficacy and Safety of Apixaban in the Treatment of Heparin Induced Thrombocytopenia (HIT)
- Status
- TERMINATED
- Phase
- PHASE2
Calf Deep Vein Thrombosis Treatment Trial
- Status
- TERMINATED
- Phase
- PHASE4
Combined Treatment With Nivolumab and Trabectedin in Patients With Metastatic or Inoperable Soft Tissue Sarcomas
- Status
- COMPLETED
- Phase
- PHASE2
Nivolumab With Standard of Care Chemotherapy for Peripheral T Cell Lymphomas
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Nivolumab in Combination With Metronomic Chemotherapy in Paediatrics Refractory / Relapsing Solid Tumors
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
Phase I/II Eval Safety & Prelim Activity Nivolumab Comb W/Vorolanib Pts W/Refractory Thoracic Tumors
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Supporting Use of AC Through Provider Profiling of Oral AC Therapy for AF
- Status
- COMPLETED
- Phase
- NA
Guadecitabine and Nivolumab in Treating Refractory Metastatic Colorectal Cancer
- Status
- WITHDRAWN
- Phase
- PHASE1/PHASE2
GMCI, Nivolumab, and Radiation Therapy in Treating Patients With Newly Diagnosed High-Grade Gliomas
- Status
- COMPLETED
- Phase
- PHASE1
A Phase I/II Study of Nivolumab, Ipilimumab and Plinabulin in Patients With Recurrent Small Cell Lung Cancer
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Nivolumab & IRX-2 With Surgery for Resectable Stage III-IVA Oral Cavity Cancer or HPV-Positive Oropharyngeal Cancer
- Status
- WITHDRAWN
- Phase
- PHASE1
Transarterial Chemoembolization in Combination With Nivolumab Performed for Intermediate Stage Hepatocellular Carcinoma
- Status
- COMPLETED
- Phase
- PHASE2
Rucaparib and Nivolumab in Patients With Prostate or Endometrial Cancer
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
Effectiveness and Safety of Nivolumab in Participants That Have Head and Neck Cancer That Has Come Back or Has Spread
- Status
- COMPLETED
- Phase
- N/A